These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 30689734)

  • 1. Dopamine restores cognitive motivation in Parkinson's disease.
    McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
    Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
    Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of Huntington's disease on cognitive and physical motivation.
    Atkins KJ; Andrews SC; Stout JC; Chong TTJ
    Brain; 2024 Jul; 147(7):2449-2458. PubMed ID: 38266149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.
    Bogdanov M; LoParco S; Otto AR; Sharp M
    Neurobiol Learn Mem; 2022 Sep; 193():107652. PubMed ID: 35724812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine enhances willingness to exert effort for reward in Parkinson's disease.
    Chong TT; Bonnelle V; Manohar S; Veromann KR; Muhammed K; Tofaris GK; Hu M; Husain M
    Cortex; 2015 Aug; 69():40-6. PubMed ID: 25967086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.
    Muhammed K; Manohar S; Ben Yehuda M; Chong TT; Tofaris G; Lennox G; Bogdanovic M; Hu M; Husain M
    Brain; 2016 Oct; 139(Pt 10):2706-2721. PubMed ID: 27452600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Dissection of Dopamine Motor and Motivational Functions in Humans.
    Le Bouc R; Rigoux L; Schmidt L; Degos B; Welter ML; Vidailhet M; Daunizeau J; Pessiglione M
    J Neurosci; 2016 Jun; 36(25):6623-33. PubMed ID: 27335396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
    Chen X; Voets S; Jenkinson N; Galea JM
    J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociable Motivational Deficits in Pre-manifest Huntington's Disease.
    Atkins KJ; Andrews SC; Stout JC; Chong TT
    Cell Rep Med; 2020 Dec; 1(9):100152. PubMed ID: 33377123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired value-based decision-making in Parkinson's disease apathy.
    Gilmour W; Mackenzie G; Feile M; Tayler-Grint L; Suveges S; Macfarlane JA; Macleod AD; Marshall V; Grunwald IQ; Steele JD; Gilbertson T
    Brain; 2024 Apr; 147(4):1362-1376. PubMed ID: 38305691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying apathy in Parkinson's disease.
    Muhammed K; Manohar S; Husain M
    Lancet; 2015 Feb; 385 Suppl 1():S71. PubMed ID: 26312893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamines Improve the Motivation to Invest Effort in Attention-Deficit/Hyperactivity Disorder.
    Chong TT; Fortunato E; Bellgrove MA
    J Neurosci; 2023 Oct; 43(41):6898-6908. PubMed ID: 37666665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effort-Based Decision-Making for Exercise in People with Parkinson's Disease.
    Colón-Semenza C; Fulford D; Ellis T
    J Parkinsons Dis; 2021; 11(2):725-735. PubMed ID: 33459665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of dopamine in the pathophysiology and treatment of apathy.
    Chong TT; Husain M
    Prog Brain Res; 2016; 229():389-426. PubMed ID: 27926449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks.
    Hosking JG; Floresco SB; Winstanley CA
    Neuropsychopharmacology; 2015 Mar; 40(4):1005-15. PubMed ID: 25328051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
    Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
    Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional effort-based decision-making underlies apathy in genetic cerebral small vessel disease.
    Le Heron C; Manohar S; Plant O; Muhammed K; Griffanti L; Nemeth A; Douaud G; Markus HS; Husain M
    Brain; 2018 Nov; 141(11):3193-3210. PubMed ID: 30346491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
    Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
    Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational modelling reveals distinct patterns of cognitive and physical motivation in elite athletes.
    Chong TT; Apps MAJ; Giehl K; Hall S; Clifton CH; Husain M
    Sci Rep; 2018 Aug; 8(1):11888. PubMed ID: 30089782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.